This study evaluated heart rate variability and its changes in 30 patients before and after transcatheter closure of secundum atrial septal defects. Heart rate variability data from 30 healthy volunteers with normal echocardiographic parameters and no history of atrial septal defects were included as controls. Values for the SD of all the normal RR intervals (SDNN), the SD of the means of all the 5-min segment normal RR intervals (SDANN), and the mean of all the 5-min SDs of normal RR intervals during the 24-h period (SDNN index) in patients with atrial septal defects before transcatheter closure were statistically significantly different from controls. At 6 months after closure of the defects these values were not statistically different from controls. It is concluded that transcatheter closure of secundum atrial septal defects had positive effects on heart rate variability and, consequently, may contribute to less mortality and morbidity.
Introduction
Secundum atrial septal defects (ASD) account for 10% of congenital heart disease cases at birth and for as much as 30% -40% of congenital heart problems in adults. 1 The most common intervention for structural heart disease is transcatheter closure (TCC) of ASD. 2 This is a safe and effective procedure that is rapidly becoming standard treatment for secundum ASD. 2, 3 The determination of heart rate variability (HRV) is a non-invasive way of assessing the effects of the autonomic nervous system in patients with sinus arrhythmia. 4 Decreased HRV has been found in various forms of heart disease including myocardial infarction, 5 congestive heart failure, 6 coronary heart disease, 7 chronic mitral regurgitation 8 and congenital heart diseases 9 such as secundum ASD, 10, 11 as well was many other medical conditions. 12, 13 It is also an independent predictor of increased mortality among patients with myocardial infarction and congestive heart disease. 14 The present cross-sectional, case-control study was designed to evaluate cardiac autonomic functions and the influence of TCC of ASD on cardiac autonomic function.
Patients and methods

STUDY POPULATION
Patients with secundum-type large ASD ('stretched' diameter > 20 mm and/or invasive QP/QS ratio > 1.5) who underwent TCC at the Department of Cardiology, Faculty of Medicine, Inonu University, M Cansel, J Yagmur, N Ermis et al.
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Malatya, Turkey between March 2009 and March 2010 were recruited into the study. Healthy volunteers attending the outpatient clinic for routine check-up and without any cardiac or non-cardiac disease, and who had normal physical examination and routine laboratory results, served as controls. All patients were evaluated for arrhythmia, ischaemic stroke, cardiac perforation, device erosion, embolization, thrombus formation, or for malposition of the device at 6 months after operation.
All patients and controls were required to have normal sinus rhythms to be elible for inclusion and were excluded if they had a history of symptomatic arrhythmias or syncope, were taking antiarrhythmic drugs, had recent or current treatment with diuretics or cardioactive drugs, had electrolytic or acid-base disturbances at baseline laboratory work-up, had valvular heart disease, ischaemic heart disease, cardiomyopathies or clinical evidence of heart failure. Patients with other congenital cardiac defects associated with ASD were also excluded.
The study was performed according to the principles of the Declaration of Helsinki and was approved by the Investigational Review Board of the School of Medicine at Inonu University. Written informed consent was obtained from all participating patients and controls.
ECHOCARDIOGRAPHY AND TCC
Transthoracic echocardiography (TTE) and transoesophageal echocardiography (TEE) were performed, using an ATL/Philips HDI-5000 echocardiography machine (Philips Medical Systems [Philips Ultrasound], Bothell, WA, USA) and a 5.0 MHz biplanar transoesophageal probe, in all patients in three different frames recorded at the same phase of the cardiac cycle as described in detail previously. 15 The following heart parameters were measured in patients before and after TCC and in controls: left ventricular ejection fraction (LVEF); left ventricular end-systolic diameter (LVESD); left atrium (LA) diameter; interventricular septum (IVS) diameter; left ventricular posterior wall (LVPW) diameter; right atrium (RA) diameter; right ventricle (RV) diameter; pulmonary artery systolic pressure (PASP); and left ventricular end-diastolic diameter (LVEDD).
The TCC procedure was performed under TEE monitoring using the Occlutech Figulla ASD Occluder (FSO) (Occlutech, Jena, Germany), as described previously. 15, 16 Aspirin (3 -5 mg/kg) was administered 24 h before the operation and continued daily for 6 months afterwards.
DETERMINATION OF HRV
Ambulatory 24-h Holter recordings before and 6 months after ASD closure were used to determine HRV. Six-channel, 24-h ambulatory electrocardiographic recordings (DMS 300-7 HolterReader; DMS, Stateline, NV, USA) were obtained for all patients and controls. Before automatic analysis of the tapes with the Holter program (CardioScan 12.0 DM software; DMS), all electrocardiographic recordings were visually reviewed by an experienced cardiologist (H.P.) and edited to delete artifacts. All data were also reviewed by the same cardiologist. There had to be ≥ 23 h of analysable data for the 24-h recording to be accepted for the study. The following timedomain HRV indices were determined: the SD of all the normal RR intervals (SDNN); the SD of the means of all the 5-min segment normal RR intervals (SDANN); the mean of all the 5-min SDs of normal RR intervals during the 24-h period (SDNN index); the root-mean square of differences between Atrial septal defect closure and heart rate variability adjacent normal RR intervals during the 24h period (rMSSD); the number of successive normal RR intervals > 50 ms during the 24-h period (sNN50); and the percentage differences between adjacent normal RR intervals that are > 50 ms during the 24-h period (pNN50). Among them, rMSSD, sNN50 and pNN50 primarily reflect parasympathetically-mediated changes in heart rate. 17 The other time-domain variables reflect a mixture of parasympathetic, sympathetic and other physiological influences.
STATISTICAL ANALYSES
Statistical analyses were carried out using the SPSS ® statistical package, version 17.0 (SPSS Inc., Chicago, IL, USA) for Windows ® . Continuous variables were expressed as mean ± SD and categorical variables were expressed as numbers and percentages. The continuous variables were determined for normality by the Shapiro-Wilk test and found to have a normal distribution. Independent t-tests and paired t-tests were used for between-group comparisons. Mann-Whitney U-tests and χ 2 tests was used for comparison of categorical variables where appropriate. A P-value < 0.05 was considered to be statistically significant.
Results
In total, 30 patients (four men, 26 women; mean ± SD age 34 ± 13 years, age range 18 -64 years) with secundum type large ASD underwent TCC and 30 healthy volunteers (six men, 24 women; mean ± SD age 29 ± 6 years, age range 19 -40 years) served as controls. There were no statistically significant differences in sex or age between the two groups. The mean ± SD diameter of the ASD was 15.6 ± 6.8 mm (range 5 -30 mm) and mean ± SD QP/QS ratio was 1.9 ± 0.4 (range 1.4 -3.3). Two of the patients with ASD had a history of cerebrovascular accident.
The HRV parameters were compared between patients before and after TCC and with controls. The values for SDNN, SDANN and SDNN index in patients with ASD before LCC were statistically significantly different from controls (P ≤ 0.005) whereas, after TCC, there was no statistically significant difference between patients and controls ( Table 1) .
The LVEF, LVEDD, LVESD and IVS values were not statistically significantly different among patients with ASD before or after TCC or compared with controls (Table 2) . Although there was no statistical difference in LVESD, it tended to a slight increase after TCC. Compared with patients with ASD before TCC, LA diameter, LVPW, RA diameter, RV diameter and PASP were significantly improved after TCC (P ≤ 0.011; Table 2 ). Values for LA diameter, LVPW and RV diameter were not statistically significantly different from the control group after LCC, whereas RA diameter and PASP remained statistically significantly higher than the control group (P = 0.001; Table 2 ).
Discussion
An isolated ASD results in left-to-right shunting which, when significant, leads to RA/RV and pulmonary arterial dilation. 18 It is now accepted that long-standing right heart, pulmonary arterial and venous volume overload and dilation in the setting of an ASD is detrimental and leads to morbidity (heart failure, arrhythmia and thromboembolic events) and increased mortality. 19, 20 Patients with ASD have increased RA, LA and RV diameters compared with individuals without ASD 21, 22 and this was also shown in the present study.
The 'ideal' ASD treatment should aim at both eliminating the intracardiac shunt and Atrial septal defect closure and heart rate variability reversing the geometric change caused by cardiac overload. 21 Transcatheter ASD device occlusion has become the treatment of choice for most secundum ASDs and appears to be beneficial, with improvements in life quality and functional capacity, reduction of pulmonary artery pressure 23 and tricuspid regurgitation, 24 and minimal complications 25, 26 such as atrial tachyarrhythmias. 27 After TCC, the heart remodels and pulmonary artery pressure decreases. 23 In some patients with ASD, dilation of the RV may subside for up to 5 years after ASD closure. 28 Others have reported progressive normalization of RV size during the first 24 months after surgical or device closure. 29 − 32 In the present study, RV diameter and PASP had decreased significantly 6 months after TCC compared with values measured before TCC in patients with ASD. Impaired cardiac autonomic nervous system activity is associated with an increased risk of sudden cardiac death in congenital cardiac disease. 33 HRV is a non-invasive method for investigating the effects of the autonomic nervous system in patients with sinus rhythm. A decrease in HRV is proportional to end-diastolic pressure in the RV, so that RV volume overload possibly induces ventricular baroreceptor dysfunction and this directly influences sympathicovagal balance. 34 Horner et al. 35 have shown in pig hearts that increased mechanical stretch of the volume-overloaded RA on the sino-atrial nodal area could alter HRV by a direct effect on diastolic depolarization within sino-atrial pacemaker cells via stretch-activated channels or a reflex-mediated response to afferent signals via neuronal stretch receptors. Atrial arrhythmias in ASD patients are the by-product of long-standing RA dilation and stretch. 36 Atrial tachyarrhythmias are common among adults with secundum ASD and contribute to substantial cardiac morbidity 37 − 39 Edwards et al. 40 have shown that atrial stretch is the principal stimulus for atrial natriuretic peptide secretion. These findings strengthen the likelihood that reduction in volume and Data presented as mean ± SD a P = 0.001 versus control; b P = 0.0001 versus before TCC; c P = 0.005 versus control; d P = 0.004 versus control); independent and paired t-tests. SDNN, the SD of all the normal RR intervals; SDANN, SD of the means of all the 5-min segment normal RR intervals; SDNN index, the mean of all the 5-min SDs of normal RR intervals during the 24-h period; rMSSD, the root-mean square of differences between adjacent normal RR intervals during the 24-h period; pNN50, the percentage differences between adjacent normal RR intervals that are > 50 ms during the 24-h period. 34, 41 Similarly, in the present study, indices of vagal activity, such as SDNN, SDANN and SDNN index values, were reduced in the ASD group compared with the control group, whereas there were no changes in rMSSD and pNN50 values, which are indices of parasympathetic system activity.
As in the present 6-month study on adults, HRV evaluated in a paediatric population with ASD following TCC reported significant improvement 3 months after TCC. 11 Decreases in cardiac parameters and improvements in time-domain HRV parameters in patients with ASD were found in the present study. The HRV parameters may be improved as a result of reduced blood volumes in the RA and RV after TCC causing a decrease in RA and RV diameters. 42 For technical reasons, only the timedomain parameters of HRV were used in the present study. The study would have been improved by inclusion of frequency-domain parameters; however, as time-domain and frequency-domain parameters are related to each other, with a change in one of them generally suggestive of a change in the other, 43 the present study still has value. In addition, a study of healthy subjects found that the time-domain HRV was better for indicating vagal activity. 44 In conclusion, the present study demonstrated that TCC of isolated secundum ASD using the novel design of the FSO device was safe and effective during the first 6 months of follow-up, and that this procedure had positive effects on HRV, potentially leading to less mortality and morbidity. These short-term findings should be evaluated in further long-term prospective studies with larger numbers of patients.
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